Simplex Trading’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,660
Closed -$525K 10103
2026
Q1
$535K Buy
+1,660
New +$514K ﹤0.01% 3170
2025
Q4
Sell
-22,529
Closed -$1.19M 9750
2025
Q3
$1.19M Sell
22,529
-2,799
-11% -$136K ﹤0.01% 2867
2025
Q2
$1.06M Buy
25,328
+22,030
+668% +$839K ﹤0.01% 2716
2025
Q1
$124K Sell
3,298
-13,556
-80% -$847K ﹤0.01% 4843
2024
Q4
$1.3M Buy
16,854
+4,436
+36% +$321K ﹤0.01% 2591
2024
Q3
$714K Buy
12,418
+10,857
+696% +$586K ﹤0.01% 3236
2024
Q2
$64K Sell
1,561
-1,794
-53% -$84.8K ﹤0.01% 5823
2024
Q1
$204K Buy
3,355
+1,963
+141% +$88.1K ﹤0.01% 4834
2023
Q4
$31K Buy
+1,392
New +$25.1K ﹤0.01% 6542
2023
Q1
Sell
-81
Closed -$3.42K 9885
2022
Q4
$2K Sell
81
-775
-91% -$24.2K ﹤0.01% 8625
2022
Q3
$29K Sell
856
-797
-48% -$39.7K ﹤0.01% 7113
2022
Q2
$60K Buy
+1,653
New +$176K ﹤0.01% 6247
2022
Q1
Sell
-9
Closed -$1.85K 11181
2021
Q4
$2K Buy
+9
New +$2.64K ﹤0.01% 10034

Other funds holding PRAX

Simplex Trading's PRAX Position: Q2 2026 in Review

Simplex Trading sold out of Praxis Precision Medicines (PRAX) in Q2 2026, closing a stake of 1,660 shares — an estimated $525K sold.

Simplex Trading first reported a position in PRAX in Q4 2021 and held it in 13 quarters. The position peaked at $1.3M in Q4 2024. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Simplex Trading reported no remaining Praxis Precision Medicines position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 1,660 Praxis Precision Medicines shares in Q2 2026, an estimated $525K.
  • Simplex Trading first reported a position in Praxis Precision Medicines in Q4 2021 and held it in 13 quarters.
  • Simplex Trading's Praxis Precision Medicines position peaked at $1.3M in Q4 2024.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.